$5.49
-0.18 (-3.17%)
Maxygen, Inc. (NASDAQ:MAXY)
CAPS Rating:
A biotechnology company committed to the discovery and development of improved next-generation protein pharmaceuticals for the treatment of disease and serious medical conditions.
RSS Headlines
Fool UK